🔎 Trials Near Me

Akèy › Kansè Vezik ki pa envazif miskilè › Kalifòni › Sacramento

Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Sacramento, CA

3 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan ak bò kote Sacramento (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Ap rekriteFaz 1
  • University of California (UC) Davis Comprehensive Cancer Center, Sacramento
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

Ap rekriteFaz 1/2
  • Golden State Urology, Sacramento
Laj 18 a 85 · Tout sèks · Mizajou Mar 27, 2026 · NCT06800963

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

Ap rekriteFaz 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT06173349

Etid Kansè Vezik ki pa envazif miskilè nan lòt vil

Lòt etid nan Sacramento

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.